Depyrogenation: Difference between revisions

Content deleted Content added
m ><
 
(36 intermediate revisions by 19 users not shown)
Line 1:
{{Short description|Removal of pyrogens from solutions}}
{{nomore footnotes|date=May 2012}}
<!-- Image with unknown copyright status removed: [[Image:Endo1.jpeg|right]] -->
'''Depyrogenation''' refers to the removal of pyrogens[[pyrogen (fever)|pyrogen]]s from [[solution (chemistry)|solution]]s, most commonly from injectable pharmaceuticals.
 
A [[wikt:pyrogen|pyrogen]] is defined as any substance that can cause a fever. Bacterial pyrogens include [[endotoxins]] and [[exotoxins]], although many pyrogens are endogenous to the host. Endotoxins include [[lipopolysaccharide]] (LPS) molecules found as part of the cell wall of [[Gram-negative]] bacteria, and are released upon bacterial cell [[lysis]]. Endotoxins may become pyrogenic when released into the bloodstream or other tissue where they are not usually found. Although the colon contains Gram-negative bacteria in abundance, they do not cause a pyrogenic effect as the bacteria are not undergoing gross lysis, and the immune system is not exposed to free endotoxin while the colonic wall is intact.
Line 10 ⟶ 11:
Because endotoxin molecular weight may vary a great deal (10,000 to 1,000,000 Da), endotoxin levels are measured in "endotoxin units" (EU). One EU is approximately equivalent to 100 pg of E. coli lipopolysaccharide—the amount present in around 10<sup>5</sup> bacteria. Humans can develop symptoms when exposed to as little as 5 EU/kg body weight. These symptoms include, but are not limited to, fever, low blood pressure, increased heart rate, and low urine output; and even small doses of endotoxin in the blood stream are often fatal.
 
The United States [[Food and Drug Administration | FDA]] has set the following maximum permissible endotoxin levels for drugs distributed in the United States:
* Drug (injectable, [[intrathecal]]) - 0.2 EU/kg body weight
* Drug (injectable, non-intrathecal) - 5 EU/kg body weight
Line 16 ⟶ 17:
 
== Pyrogen detection ==
'''Rabbit Test'''
 
'''=== Rabbit Test''' ===
Early endotoxin detection was accomplished by injecting rabbits with the sample and observing the response in their body temperature. Rabbits have similar endotoxin tolerance to humans, and were thus an ideal choice. However, this method was costly, time consuming, and prompted protests from animals rights advocates. But perhaps the biggest drawback of this test was its inability to quantify the endotoxin level.
 
'''[[=== LAL test]]''' ===
{{main|Limulus Amebocyte Lysate}}
Currently, theone common method of choice for endotoxin detection is the [[Limulus Amebocyte Lysate]] (LAL) test. This test is based on Dr. Frederik Bang's [http://commprojects.jhsph.edu/sphheros/default.cfm?detail=17] observation that horseshoe crab blood forms clots when exposed to endotoxins.<ref>{{cite web |last1=Greer |first1=Spencer |last2=Health |first2=JH Bloomberg School of Public |title=Frederik Bang |url=https://www.jhsph.edu/about/history/heroes-of-public-health/frederik-bang.html |website=Johns Hopkins Bloomberg School of Public Health}}</ref> Amoebocyte extract from horseshoe crab blood is mixed with a sample suspected of endotoxin contamination, and a reaction is observed if endotoxins are present. The FDA has approved four variations of the LAL test: gel-clot, turbidimetric, colorimetric, and chromogenic assay. The differences in these variations refer to the characteristics of the amoebocyte/endtoxin reaction (e.g. gel-clot produces a precipitate and colorimetric changes color). This test is fast (approx. 30 minutes) and highly sensitive (up to 0.005001 EU/ml sensitivity). However, because it only detects LPS endotoxins, some pyrogenic materials can be missed. Also, certain conditions (sub-optimal pH conditions or unsuitable [[cation]] concentration) can lead to false negatives. [[Glucans]] from carbohydrate chromatography matrices can also lead to false positives.<ref>[Sandle, T. (2013). Pharmaceutical Product Impurities: Considering Beta Glucans, American Pharmaceutical Review, 16 (5) Supplement S1: 16-19]</ref>
 
Since 2003, a synthetic substitute for the LAL test has been commercially available. This recombinant factor C (rFC) test is based on [[Limulus clotting factor C]], the LPS-sensitive part of LAL. The adoption of this test was slow, which began to change in 2016 when the [[European Pharmacopoeia]] listed this test as an accepted bacterial-toxin test.<ref name="rfc">{{cite journal |last1=Maloney |first1=Tom |last2=Phelan |first2=Ryan |last3=Simmons |first3=Naira |title=Saving the horseshoe crab: A synthetic alternative to horseshoe crab blood for endotoxin detection |journal=PLOS Biology |date=12 October 2018 |volume=16 |issue=10 |pages=e2006607 |doi=10.1371/journal.pbio.2006607|pmid=30312293 |pmc=6200278 |doi-access=free }}</ref>
Currently, the method of choice for endotoxin detection is the [[Limulus Amebocyte Lysate]] (LAL) test. This test is based on Dr. Frederik Bang's [http://commprojects.jhsph.edu/sphheros/default.cfm?detail=17] observation that horseshoe crab blood forms clots when exposed to endotoxins. Amoebocyte extract from horseshoe crab blood is mixed with a sample suspected of endotoxin contamination, and a reaction is observed if endotoxins are present. The FDA has approved four variations of the LAL test: gel-clot, turbidimetric, colorimetric, and chromogenic assay. The differences in these variations refer to the characteristics of the amoebocyte/endtoxin reaction (e.g. gel-clot produces a precipitate and colorimetric changes color). This test is fast (approx. 30 minutes) and highly sensitive (up to 0.005 EU/ml sensitivity). However, because it only detects LPS endotoxins, some pyrogenic materials can be missed. Also, certain conditions (sub-optimal pH conditions or unsuitable [[cation]] concentration) can lead to false negatives. [[Glucans]] from carbohydrate chromatography matrices can also lead to false positives.
 
=== Monocyte Activation Test ===
The [[Monocyte Activation Test]] (MAT) uses the [[monocyte]]s in human blood ''[[in vitro]]'' to detect pyrogens. It was added to the European Pharmacopoeia in 2010 and accepted by the FDA in 2012.<ref>{{cite web|url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pyrogen-and-endotoxins-testing-questions-and-answers|title=Guidance for Pyrogen and Endotoxins Testing: Questions and Answers|publisher=[[Food and Drug Administration]] (FDA)|date=June 2012|archive-url=https://web.archive.org/web/20220125135845/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pyrogen-and-endotoxins-testing-questions-and-answers|archive-date=January 25, 2022}}</ref>
 
== Pyrogen removal (depyrogenation) ==
Pyrogens can often be difficult to remove from solution due to the high variability of their molecular weight. Pyrogens are also relatively thermally stable and insensitive to pH changes. However, several removal techniques exist.<ref>{{cite journal |last1=Sandle |first1=Tim |title=A Practical Approach to Depyrogenation Studies Using Bacterial Endotoxin |journal=Journal of GXP Compliance |date=October 2011 |volume=15 |issue=4 |url=https://www.researchgate.net/publication/282704534}}</ref>
 
'''[[===Ion exchange chromatography]]'''===
{{main|Ion exchange chromatography}}
:Endotoxins are negatively charged, and will bind to an ''[[anion exchanger]]''. If the target substance is not also negatively charged, it will pass through the column before the endotoxin, and an effective separation can be achieved. This method is sometimes used in the purification of [[albumins]] (details follow). [[Ligands]] of known affinity to endotoxins can be coupled to an anion exchange system to increase its endotoxin binding strength and further improve the purity of the final product. Typical examples of endotoxin binding ligands include [[histamine]], nitrogen-containing heterocyclic compounds, and [[polymyxin B]]. However, [[polymyxin B]] is known to induce production of interleukin-1, an exogenous pyrogen, and thus must be shown to be absent in the final product if used.
*: Example of using [[anion exchange chromatography]] to purify albumin:<ref>''Chromatographic Removal of Endotoxins and/or Ethanol from Albumin. Application Note 206.'' Pharmacia Biotech., Uppsala, 1990.</ref>
:* 2% of the endotoxin ''does not'' bind to the column. However, this 2% washes out before the albumin peak, and can thus be removed simply by starting collection after this 2% has washed out.
:* 10% of the endotoxin that ''does'' bind to the column (9.8% of the original total) will eventually wash out after the albumin peak. This can be prevented from entering the final product by stopping collection before this happens.
:* The remaining 90% of the bound endotoxin (88.2% of the original total) must be cleaned off the column using NaOH
: An alternative to anion exchange is ''[[cation exchange]] chromatography'', in which positively charged solutes bind to the solid chromatographic media. In this method, the target binds to the column instead of the endotoxin. The endotoxin then washes through the column, and a pure target is later eluted off the column. Cation exchange chromatography has been shown to effectively purify β-interferon. (Dembinski, et al.)<ref>Dembinski, W.; O'Malley, J.A.; Sulkowski, E. Large Scale Purification Procedure for Human Fibroblast Interferon. ''Interferon Scientific Memoranda'', Jan./Feb., 6 (1983).</ref>
 
'''[[===Ultrafiltration]]'''===
Endotoxins are negatively charged, and will bind to an ''[[anion exchanger]]''. If the target substance is not also negatively charged, it will pass through the column before the endotoxin, and an effective separation can be achieved. This method is sometimes used in the purification of [[albumins]] (details follow). [[Ligands]] of known affinity to endotoxins can be coupled to an anion exchange system to increase its endotoxin binding strength and further improve the purity of the final product. Typical examples of endotoxin binding ligands include [[histamine]], nitrogen-containing heterocyclic compounds, and [[polymyxin B]]. However, [[polymyxin B]] is known to induce production of interleukin-1, an exogenous pyrogen, and thus must be shown to be absent in the final product if used.
{{main|Ultrafiltration}}
:Because the molecular weight of endotoxins is usually over 10 kD, ultrafiltration can sometimes be used to perform as a size based separation. Due to the high variability of endotoxin size, it can be difficult to select the correct membrane, hence this method is best used only when all endotoxins present are larger than 300,000 Da. Commercially available ultra filters have been shown to remove pyrogens to a level below 0.001 EU/ml.{{citation needed|date=November 2010}}
 
'''[[===Distillation]]'''===
Example of using [[anion exchange chromatography]] to purify albumin (Uppsala):
{{main|Distillation}}
* 2% of the endotoxin ''does not'' bind to the column. However, this 2% washes out before the albumin peak, and can thus be removed simply by starting collection after this 2% has washed out.
:This method is also based on the large molecular weight and heat stability of endotoxins. Low molecular-weight solvents can be easily purified by boiling and collecting the condensed vapor in an endotoxin free vessel (see "heating" below). The large LPS molecules do not easily vaporize, and are thus left behind in the heating vessel. This is the method of choice for the purification of water.
* 10% of the endotoxin that ''does'' bind to the column (9.8% of the original total) will eventually wash out after the albumin peak. This can be prevented from entering the final product by stopping collection before this happens.
* The remaining 90% of the bound endotoxin (88.2% of the original total) must be cleaned off the column using NaOH
 
An alternative to anion exchange is ''[[cation exchange]] chromatography'', in which positively charged solutes bind to the solid chromatographic media. In this method, the target binds to the column instead of the endotoxin. The endotoxin then washes through the column, and a pure target is later eluted off the column. Cation exchange chromatography has been shown to effectively purify β-interferon. (Dembinski, et al.)
 
'''[[Ultrafiltration]]'''
 
Because the molecular weight of endotoxins is usually over 10 kD, ultrafiltration can sometimes be used to perform as a size based separation. Due to the high variability of endotoxin size, it can be difficult to select the correct membrane, hence this method is best used only when all endotoxins present are larger than 300,000 Da. Commercially available ultra filters have been shown to remove pyrogens to a level below 0.001 EU/ml.{{citation needed|date=November 2010}}
 
'''[[Distillation]]'''
 
This method is also based on the large molecular weight and heat stability of endotoxins. Low molecular-weight solvents can be easily purified by boiling and collecting the condensed vapor in an endotoxin free vessel (see "heating" below). The large LPS molecules do not easily vaporize, and are thus left behind in the heating vessel. This is the method of choice for the purification of water.
 
== Inactivation/destruction ==
Because pyrogens are often difficult to remove, inactivation or destruction of the LPS molecule can sometimes be preferable.
 
'''===Acid-base [[hydrolysis]]''' ===
{{main|Hydrolysis}}
<!-- Image with unknown copyright status removed: [[Image:Endo3.jpeg|right]] -->
This method has been shown to cleave Lipid A from the polysaccharide in the LPS molecule (see right). The [[lipid]] moiety alone is not soluble in water. Thus unable to bind to [[endothelial]] cells, it is rendered inactive. However, acid-base hydrolysis can denature a target protein, and is thus unsuitable when purifying a protein.
 
'''[[===Oxidation]]'''===
{{main|Oxidation}}
 
Oxidation using hydrogen peroxide is often used as a low cost pyrogen destroying solution. The mechanism for this destruction is unknown, but hydrogen peroxide can easily be removed further downstream in the purification process, and is therefore a useful method of pyrogen removal. However, like acid-base hydrolysis, it is not suitable when purifying proteins.
'''===Heating'''===
Heating methods are often used to ensure that glass and other lab equipment are free of pyrogenic material. Heat is applied by baking in a dry heat oven that is designed specifically for the depyrogenation process. Although endotoxins are relatively thermally stable, sufficient heating (250&nbsp;°C for 30 min) results in a 3log[[Log reduction|3-log reduction]] of endotoxin levels. Due to the high temperature levels, this method is also not suitable when purifying proteins.
 
===Alkalies===
'''Heating'''
{{main|Alkali}}
 
When purifying proteins, alkalies such as sodium hydroxide (NaOH) can be used safely and effectively. It is also widely used for depyrogenation of non-autoclavable equipment (e.g. plastics) and chromatography columns. In fact, when using an anion exchanger to remove pyrogens, it is necessary to clean the column with NaOH after each batch.
Heating methods are often used to ensure that glass and other lab equipment are free of pyrogenic material. Heat is applied by baking in a dry heat oven that is designed specifically for the depyrogenation process. Although endotoxins are relatively thermally stable, sufficient heating (250°C for 30 min) results in a 3log reduction of endotoxin levels. Due to the high temperature levels, this method is also not suitable when purifying proteins.
 
'''Sodium Hydroxide'''
 
When purifying proteins, sodium hydroxide (NaOH) can be used safely and effectively. It is also widely used for depyrogenation of non-autoclavable equipment (e.g. plastics) and chromatography columns. In fact, when using an anion exchanger to remove pyrogens, it is necessary to clean the column with NaOH after each batch.
 
== Preventive methods ==
Line 73 ⟶ 76:
 
== References ==
{{Reflist}}
* Sofer, G.; Hagel, L. (1997). Handbook of Process Chromatography: A guide to Optimization, Scale-up, and Validation. Academic Press, 158-161. {{ISBN |0-12-654266-X}}
* Tours, N. and Sandle, T. Comparison of dry-heat depyrogenation using three different types of Gram-negative bacterial endotoxin, European Journal of Parenteral and Pharmaceutical Sciences, Volume 13, No.1, 2008, pp17–20pp. 17–20
 
==External links==
{{Prone to spam|date=October 2022}}
<!-- {{No more links}}
 
Please be cautious adding more external links.
 
Wikipedia is not a collection of links and should not be used for advertising.
 
Excessive or inappropriate links will be removed.
 
See [[Wikipedia:External links]] and [[Wikipedia:Spam]] for details.
 
If there are already suitable links, propose additions or replacements on
the article's talk page.
 
-->
*[http://www.acciusa.com/bet/update/index.html LAL Update]
*[http://www.acciusa.com/pdfs/newsletter/LAL_Vol.11No.5.pdf.html Depyrogenation LAL Update]
* [httphttps://www.fda.gov/ICECI/Inspections/InspectionGuides/InspectionTechnicalGuides/ucm072918.htm FDA Office of Regulatory Affairs: Inspection Technical Guide, Bacterial Endotoxins/Pyrogens]
* Sofer, G.; Hagel, L. (1997). Handbook of Process Chromatography: A guide to Optimization, Scale-up, and Validation. Academic Press, 158-161. ISBN 0-12-654266-X
* [http://textbookofbacteriology.net/endotoxin.html Textbook of Bacteriology]
* [http://www.fda.gov/ICECI/Inspections/InspectionGuides/InspectionTechnicalGuides/ucm072918.htm FDA Office of Regulatory Affairs: Inspection Technical Guide, Bacterial Endotoxins/Pyrogens]
* [http://www.horseshoecrab.org/med/med.html Horseshoe Crab Medical Uses]
* [http://textbookofbacteriology.net/endotoxin.html Textbook of Bacteriology]
*[https://www.researchgate.net/publication/282704534_A_Practical_Approach_to_Depyrogenation_Studies_Using_Bacterial_Endotoxin A Practical Approach to Depyrogenation Studies Using Bacterial Endotoxin]
* [http://www.horseshoecrab.org/med/med.html Horseshoe Crab Medical Uses]
* ''Chromatographic Removal of Endotoxins and/or Ethanol from Albumin. Application Note 206.'' Pharmacia Biotech., Uppsala, 1990.
* Dembinski, W.; O'Malley, J.A.; Sulkowski, E. Large Scale Purification Procedure for Human Fibroblast Interferon. ''Interferon Scientific Memoranda'', Jan./Feb., 6 (1983).
* Tours, N. and Sandle, T. Comparison of dry-heat depyrogenation using three different types of Gram-negative bacterial endotoxin, European Journal of Parenteral and Pharmaceutical Sciences, Volume 13, No.1, 2008, pp17–20
 
[[Category:Toxicology]]
 
[[de:Pyrogen]]